511 related articles for article (PubMed ID: 22340817)
1. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease.
Yoneda M; Naka S; Nakano K; Wada K; Endo H; Mawatari H; Imajo K; Nomura R; Hokamura K; Ono M; Murata S; Tohnai I; Sumida Y; Shima T; Kuboniwa M; Umemura K; Kamisaki Y; Amano A; Okanoue T; Ooshima T; Nakajima A
BMC Gastroenterol; 2012 Feb; 12():16. PubMed ID: 22340817
[TBL] [Abstract][Full Text] [Related]
2. Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease.
Nakahara T; Hyogo H; Ono A; Nagaoki Y; Kawaoka T; Miki D; Tsuge M; Hiraga N; Hayes CN; Hiramatsu A; Imamura M; Kawakami Y; Aikata H; Ochi H; Abe-Chayama H; Furusho H; Shintani T; Kurihara H; Miyauchi M; Takata T; Arihiro K; Chayama K
J Gastroenterol; 2018 Feb; 53(2):269-280. PubMed ID: 28741270
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial.
Kamata Y; Kessoku T; Shimizu T; Kobayashi T; Kurihashi T; Sato S; Kuraji S; Aoyama N; Iwasaki T; Takashiba S; Hamada N; Kodama T; Tamura T; Ino S; Higurashi T; Taguri M; Yamanaka T; Yoneda M; Usuda H; Wada K; Nakajima A; Minabe M
Trials; 2020 Mar; 21(1):291. PubMed ID: 32293522
[TBL] [Abstract][Full Text] [Related]
4. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice.
Furusho H; Miyauchi M; Hyogo H; Inubushi T; Ao M; Ouhara K; Hisatune J; Kurihara H; Sugai M; Hayes CN; Nakahara T; Aikata H; Takahashi S; Chayama K; Takata T
J Gastroenterol; 2013 Nov; 48(11):1259-70. PubMed ID: 23307045
[TBL] [Abstract][Full Text] [Related]
5. Impact of
Liu L; Geng Y; Xiong C
Ann Med; 2023; 55(2):2255825. PubMed ID: 37708866
[No Abstract] [Full Text] [Related]
6. Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathway.
Ahn JS; Yang JW; Oh SJ; Shin YY; Kang MJ; Park HR; Seo Y; Kim HS
BMB Rep; 2021 Jun; 54(6):323-328. PubMed ID: 34078528
[TBL] [Abstract][Full Text] [Related]
7. Porphyromonas gingivalis-derived lipopolysaccharide causes excessive hepatic lipid accumulation via activating NF-κB and JNK signaling pathways.
Ding LY; Liang LZ; Zhao YX; Yang YN; Liu F; Ding QR; Luo LJ
Oral Dis; 2019 Oct; 25(7):1789-1797. PubMed ID: 31283861
[TBL] [Abstract][Full Text] [Related]
8. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis.
Kuraji R; Shiba T; Dong TS; Numabe Y; Kapila YL
World J Gastroenterol; 2023 Feb; 29(6):967-996. PubMed ID: 36844143
[TBL] [Abstract][Full Text] [Related]
9. Porphyromonas gingivalis triggers inflammation in hepatocyte depend on ferroptosis via activating the NF-κB signaling pathway.
Yao C; Lan D; Li X; Wang Y; Qi S
Oral Dis; 2024 Apr; 30(3):1680-1694. PubMed ID: 36939447
[TBL] [Abstract][Full Text] [Related]
10. Experimental periodontitis induced by Porphyromonas gingivalis does not alter the onset or severity of diabetes in mice.
Li H; Yang H; Ding Y; Aprecio R; Zhang W; Wang Q; Li Y
J Periodontal Res; 2013 Oct; 48(5):582-90. PubMed ID: 23317150
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the toxicological role of Porphyromonas gingivalis derived endotoxins in liver diseases.
Ezhilarasan D
Environ Toxicol Pharmacol; 2021 Nov; 88():103755. PubMed ID: 34662732
[TBL] [Abstract][Full Text] [Related]
12. Oral Pathobiont-Induced Changes in Gut Microbiota Aggravate the Pathology of Nonalcoholic Fatty Liver Disease in Mice.
Yamazaki K; Kato T; Tsuboi Y; Miyauchi E; Suda W; Sato K; Nakajima M; Yokoji-Takeuchi M; Yamada-Hara M; Tsuzuno T; Matsugishi A; Takahashi N; Tabeta K; Miura N; Okuda S; Kikuchi J; Ohno H; Yamazaki K
Front Immunol; 2021; 12():766170. PubMed ID: 34707622
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional study assessing the relationship between non-alcoholic fatty liver disease and periodontal disease.
Sato S; Kamata Y; Kessoku T; Shimizu T; Kobayashi T; Kurihashi T; Takashiba S; Hatanaka K; Hamada N; Kodama T; Higurashi T; Taguri M; Yoneda M; Usuda H; Wada K; Nakajima A; Morozumi T; Minabe M
Sci Rep; 2022 Aug; 12(1):13621. PubMed ID: 35948584
[TBL] [Abstract][Full Text] [Related]
14. Treponema socranskii, Treponema denticola, and Porphyromonas gingivalis are associated with severity of periodontal tissue destruction.
Takeuchi Y; Umeda M; Sakamoto M; Benno Y; Huang Y; Ishikawa I
J Periodontol; 2001 Oct; 72(10):1354-63. PubMed ID: 11699477
[TBL] [Abstract][Full Text] [Related]
15. Relationship between herpesviruses and adult periodontitis and periodontopathic bacteria.
Contreras A; Umeda M; Chen C; Bakker I; Morrison JL; Slots J
J Periodontol; 1999 May; 70(5):478-84. PubMed ID: 10368051
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of periodontal disease in patients with NASH- possible association of poor dental health with NASH severity.
Pischke S; Shiprov A; Peters U; Schulze Zur Wiesch J; Kluwe J; Westphal T; Fischer F; Mader M; Fründt T; Horvatits K; Horvatits T; Aarabi G; Beikler T
Ann Hepatol; 2023; 28(2):100887. PubMed ID: 36646168
[TBL] [Abstract][Full Text] [Related]
17. Relationship of periodontal infection to serum antibody levels to periodontopathic bacteria and inflammatory markers in periodontitis patients with coronary heart disease.
Yamazaki K; Honda T; Domon H; Okui T; Kajita K; Amanuma R; Kudoh C; Takashiba S; Kokeguchi S; Nishimura F; Kodama M; Aizawa Y; Oda H
Clin Exp Immunol; 2007 Sep; 149(3):445-52. PubMed ID: 17645769
[TBL] [Abstract][Full Text] [Related]
18.
Kuraji R; Ito H; Fujita M; Ishiguro H; Hashimoto S; Numabe Y
Clin Exp Dent Res; 2016 Dec; 2(3):216-225. PubMed ID: 29744170
[TBL] [Abstract][Full Text] [Related]
19. The potential association between periodontitis and non-alcoholic fatty liver disease: a systematic review.
Alakhali MS; Al-Maweri SA; Al-Shamiri HM; Al-Haddad K; Halboub E
Clin Oral Investig; 2018 Dec; 22(9):2965-2974. PubMed ID: 30357481
[TBL] [Abstract][Full Text] [Related]
20. Elimination of Porphyromonas gingivalis inhibits liver fibrosis and inflammation in NASH.
Nagasaki A; Sakamoto S; Arai T; Kato M; Ishida E; Furusho H; Fujii M; Takata T; Miyauchi M
J Clin Periodontol; 2021 Oct; 48(10):1367-1378. PubMed ID: 34250613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
